Viewing Study NCT02478502


Ignite Creation Date: 2025-12-25 @ 3:56 AM
Ignite Modification Date: 2026-01-10 @ 2:22 PM
Study NCT ID: NCT02478502
Status: TERMINATED
Last Update Posted: 2024-02-02
First Post: 2014-08-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Testis CAB: Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell Cancer
Sponsor: University Hospital, Akershus
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-06
Start Date Type: None
Primary Completion Date: 2022-12-31
Primary Completion Date Type: ACTUAL
Completion Date: 2022-12-31
Completion Date Type: ACTUAL
First Submit Date: 2014-08-28
First Submit QC Date: None
Study First Post Date: 2015-06-23
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-02-01
Last Update Post Date: 2024-02-02
Last Update Post Date Type: ACTUAL